We would like to invite you to the joint event of the BioPharma Cluster South Germany and the German Society for Biochemistry and Molecular Biology (GBM)!

With this event we would like to bridge the gap between basic university research in the field of RNA and industrial research and application. In addition, we would like to discuss opportunities and challenges in the manufacturing of New Biologic Modalities incl RNA therapeutics.
Moreover, we offer participants including young scientists the opportunity to exchange ideas and network with Executives of the BioPharma Cluster.

We would be pleased to welcome you on December 1^st at the “Stadthaus” in Ulm and look forward to an inspiring meeting!

Programm

13:00 - 14:30 I    From Basic Research to RNA Therapeutics

                            Lennart Randau /Philipps-Universität Marburg
                            The diversity of non-coding RNA functions

                            Mark Helm /Johannes-Gutenberg-Universität Mainz
                            RNA modifications in medicinal RNA

                            Dierk Niessing /Universität Ulm
                            A molecule with multiple faces: RNA as cause of diseases, as drug target, and as therapeutic tool

14:30 - 15:30 I    BNT162b2 – An Innovative Vaccination Platform

                            Tilman Friedland /BioNTech, Mainz
                            Chances and Development Potentialities of BNT162b2

15:30 - 16:00 I    Coffee Break

16:00 - 17:00 I    Panel Discussion: Opportunities and Manufacturing Challenges

                            Moderator:
                            Uwe Bücheler /Senior Advisor Biopharmaceuticals, Boehringer Ingelheim

                            Guests:
                            Christiane Bardroff /Senior Vice President Client Program Management, Rentschler Biopharma
                            Stefan Ottmar Fügenschuh /VP Site GM Biologic Manufacturing, Supply Operations, Teva Biotech
                            Claus Feußner /Senior Vice President Development Service, Vetter Pharma-Fertigung
                            Hugo de Wit /CEO Sartorius Stedim Cellca (requested)
                            Tilman Friedland /BioNTech

17:00 - 18:00 I    Career Roundtable

                            Speed Dating with Biopharma Cluster Companies (Rentschler Biopharma, Teva, Vetter, Sartorius,
                            Boehringer Ingelheim) - exclusive opportunity for Postdocs, PhD students and graduates (with master
                            degree) to exchange ideas with executives from industry

from 18:00 on    Networking & Fingerfood